A Clinical Study of SI-B001 Combined With Docetaxel in the Treatment of Non-small Cell Lung Adenocarcinoma and Lung Squamous Cell Carcinoma

NCT05943795 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

589

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-small Cell Lung Adenocarcinoma
Squamous Cell Carcinoma of Lung

Interventions

DRUG: SI-B001
DRUG: Docetaxel

Sponsor

Sichuan Baili Pharmaceutical Co., Ltd.